Rekha Hemrajani insider trades: Maxcyte (MXCT) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Rekha reports to the SEC
and 1 more company
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 25, 2025 | MXCT | ↓ Sell | 10,684 | $2.09 | $22K | Direct | Aug 27, 2025 (63d) |
| Dec 2, 2024 | ALXO | ↑ Buy | 30,000 | $1.55 | $46K | Direct | Dec 4, 2024 (2d) |
| Jul 21, 2020 | ALXO | ↑ Buy | 3,000 | $19.00 | $57K | Direct | Jul 21, 2020 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other MXCT insiders
Open-market trades in the last 12 months
About Rekha Hemrajani's insider trades
Rekha Hemrajani is an insider at Maxcyte (MXCT). Since Jul 21, 2020, Rekha has reported 2 open-market purchases worth $103K and 1 sale worth $22K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (23 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MXCT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.